National Institute of Mental Health; Notice of Meeting, 3799-3800 [2019-02125]

Download as PDF Federal Register / Vol. 84, No. 30 / Wednesday, February 13, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Meeting khammond on DSKBBV9HB2PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of an Interagency Autism Coordinating Committee (IACC or Committee) meeting. The purpose of the IACC meeting is to discuss business, agency updates, and issues related to autism spectrum disorder (ASD) research and services activities. The meeting will be open to the public and will be accessible by webcast and conference call. Close captioning is provided; for other disabilities accommodations see below. Name of Committee: Interagency Autism Coordinating Committee. Type of meeting: Open Meeting. Date: Wednesday, April 17, 2019. Time: 9:00 a.m. to 5:00 p.m.* Eastern Time * Approximate end time. Agenda: To discuss business, updates, and issues related to ASD research and services activities. Place: Neuroscience Center, 6001 Executive Blvd., Conference Room C and D, Rockville, MD 20892. Webcast Live: https://videocast.nih.gov/ summary.asp?live=31473. Conference Call Access: Dial: 800–369– 3337 Access code: 9975399. Cost: The meeting is free and open to the public. Registration: A registration web link will be posted on the IACC website (www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended to expedite check-in. Seating in the meeting room is limited to room capacity and on a first come, first served basis.Onsite registration will also be available. Deadlines: Notification of intent to present oral comments: Thursday, April 4, 2019 by 5:00 p.m. ET. Submission of written/ electronic statement for oral comments: Tuesday, April 9, 2019 by 5:00 p.m. ET. Submission of written comments: Tuesday, April 9, 2019 by 5:00 p.m. ET. Webcast Live Feedback Public comments: No preregistration required. For instructions, see https://iacc.hhs.gov/meetings/iacc-meetings/ live-feedback.shtml. For IACC Public Comment guidelines please see: https:// iacc.hhs.gov/meetings/public-comments/ guidelines/. Access: White Flint Metro Station (Red Line). Contact Person: Ms. Angelice Mitrakas, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, Room 6182A, Bethesda, MD 20892–9669, Phone: 301–435– 9269, Email: IACCPublicInquiries@ mail.nih.gov. Public Comments: Any member of the public interested in presenting oral VerDate Sep<11>2014 17:22 Feb 12, 2019 Jkt 247001 comments to the IACC must notify the Contact Person listed on this notice by 5:00 p.m. ET on Thursday, April 4, 2019 with their request to present oral comments at the meeting, and a written/ electronic copy of the oral presentation/ statement must be submitted by 5:00 p.m. ET on Tuesday, April 9, 2019. A limited number of slots for oral comment are available, and in order to ensure that as many different individuals are able to present throughout the year as possible, any given individual only will be permitted to present oral comments once per calendar year (2019). Only one representative of an organization will be allowed to present oral comments in any given meeting; other representatives of the same group may provide written comments. If the oral comment session is full, individuals who could not be accommodated are welcome to provide written comments instead. Comments to be read or presented in the meeting will be assigned a 3–5 minute time slot depending on the number of comments, but a longer version may be submitted in writing for the record. Commenters going beyond their allotted time in the meeting may be asked to conclude immediately in order to allow other comments and presentations to proceed on schedule. Any interested person may submit written public comments to the IACC prior to the meeting by emailing the comments to IACCPublicInquiries@ mail.nih.gov or by submitting comments at the web link: https://iacc.hhs.gov/ meetings/public-comments/submit/ index.jsp by 5:00 p.m. ET on Tuesday, April 9, 2019. The comments should include the name, address, telephone number, and when applicable, the business or professional affiliation of the interested person. NIMH anticipates written public comments received by 5:00 p.m. ET on Tuesday, April 9, 2019 will be presented to the Committee prior to the meeting for the Committee’s consideration. Any written comments received after the 5:00 p.m. ET, April 9, 2019 deadline through April 16, 2019 will be provided to the Committee either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. All written public comments and oral public comment statements received by the deadlines for both oral and written public comments will be provided to the IACC for their consideration and will become part of the public record. Attachments of copyrighted publications are not PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 3799 permitted, but web links or citations for any copyrighted works cited may be provided. Individuals may also submit public comments to the IACC via a Live Feedback Form accessible from the webcast page on the day of the meeting from 9:00 a.m. ET to 11:00 a.m. ET. No pre-registration required. The link will be accessible on the NIH Videocast website at https://videocast.nih.gov/ summary.asp?live=31473 and instructions are available on the IACC website: https://iacc.hhs.gov/meetings/ iacc-meetings/live-feedback.shtml. This format is best suited for brief questions and comments for the committee. Submissions will be provided to the IACC and will become a part of the public record. In the 2016–2017 IACC Strategic Plan, the IACC listed the ‘‘Spirit of Collaboration’’ as one of its core values, stating that, ‘‘We will treat others with respect, listen with open minds to the diverse views of people on the autism spectrum and their families, thoughtfully consider community input, and foster discussions where participants can comfortably where participants can comfortably offer opposing opinions.’’ In keeping with this core value, the IACC and the NIMH Office of Autism Research Coordination (OARC) ask that members of the public who provide public comments or participate in meetings of the IACC also seek to treat others with respect and consideration in their communications and actions, even when discussing issues of genuine concern or disagreement. Remote Access: The meeting will be open to the public through a conference call phone number and webcast live on the internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the webcast or conference call, please send an email to IACCPublicInquiries@ mail.nih.gov or call 240–668–0302. Disability Accommodations: All IACC Full Meetings provide Closed Captioning through the NIH videocast website. Remote CART is provided through a web application and will be available at all meetings; the application can be used on a laptop computer or mobile device. For details please inquire with the Contact Person listed on the notice. Individuals whose full participation in the meeting will require special accommodations (e.g., sign language, or interpreting services, etc.) must submit a request to the Contact Person listed on the notice at least seven (7) business E:\FR\FM\13FEN1.SGM 13FEN1 3800 Federal Register / Vol. 84, No. 30 / Wednesday, February 13, 2019 / Notices days prior to the meeting. Such requests should include a detailed description of the accommodation needed and a way for the IACC to contact the requester if more information is needed to fill the request. Special requests should be made as early as possible; last minute requests may be made but may not be possible to accommodate. Security: Visitors will be asked to sign in and show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) at the meeting registration desk during the check-in process. Pre-registration is recommended. Seating will be limited to the room capacity and seats will be on a first come, first served basis, with expedited check-in for those who are pre-registered. Meeting schedule subject to change. Information about the IACC is available on the website: https:// www.iacc.hhs.gov. Dated: February 7, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting khammond on DSKBBV9HB2PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.) notice is hereby given of a meeting of the Board of Scientific Counselors Chairs Meeting, National Institutes of Health. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Board of Scientific Counselors, National Institutes of Health. Date: May 17, 2019. Time: 10:00 a.m. to 2:00 p.m. Agenda: The meeting will include a discussion of policies and procedures that apply to the regular review of NIH intramural scientists and their work. Place: National Institutes of Health, 1 Center Drive, Building 1, 3rd Floor, Wilson Hall, Bethesda, MD 20892. Conference Line Access: Dial: 1–888–233– 9215 Participant Passcode: 58358. Contact Person: Margaret McBurney, Program Specialist, Office of the Deputy Director for Intramural Research, Office of 17:22 Feb 12, 2019 Jkt 247001 Dated: February 7, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–02129 Filed 2–12–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings [FR Doc. 2019–02125 Filed 2–12–19; 8:45 am] VerDate Sep<11>2014 the Director, National Institutes of Health, 1 Center Drive, Room 160, Bethesda, MD 20892, mmburney@od.nih.gov, Phone: (301) 496–1921, Fax: (301) 402–4273. Information is also available on the Office of Intramural Research home page: https:// sourcebook.od.nih.gov/. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–MH– 19–412: Reducing Intersectional Stigma to Improve the HIV/AIDS Prevention Continuum. Date: March 27, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Shalanda A. Bynum, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301–755–4355, bynumsa@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: AIDS and Related Research. Date: March 28, 2019. Time: 10:00 a.m. to 4:00 p.m. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Karen Nieves Lugo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892, karen.nieveslugo@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: AIDS and Related Research. Date: March 29, 2019. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Karen Nieves Lugo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892, karen.nieveslugo@nih.gov. Name of Committee: Biology of Development and Aging Integrated Review Group; International and Cooperative Projects—1 Study Section. Date: April 2–3, 2019. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Seetha Bhagavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 237– 9838, bhagavas@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR16–366: Research in Biomedicine and Agriculture. Date: April 2, 2019. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Raul Rojas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6185, Bethesda, MD 20892, (301) 451–6319, rojasr@ mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cardiovascular Sciences. Date: April 3, 2019. Time: 12:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Chee Lim, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4128, Bethesda, MD 20892, 301– 435–1850, limc4@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Immunology AREA Review. E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 84, Number 30 (Wednesday, February 13, 2019)]
[Notices]
[Pages 3799-3800]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02125]



[[Page 3799]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of an Interagency Autism Coordinating 
Committee (IACC or Committee) meeting.
    The purpose of the IACC meeting is to discuss business, agency 
updates, and issues related to autism spectrum disorder (ASD) research 
and services activities. The meeting will be open to the public and 
will be accessible by webcast and conference call. Close captioning is 
provided; for other disabilities accommodations see below.

    Name of Committee: Interagency Autism Coordinating Committee.
    Type of meeting: Open Meeting.
    Date: Wednesday, April 17, 2019.
    Time: 9:00 a.m. to 5:00 p.m.* Eastern Time * Approximate end 
time.
    Agenda: To discuss business, updates, and issues related to ASD 
research and services activities.
    Place: Neuroscience Center, 6001 Executive Blvd., Conference 
Room C and D, Rockville, MD 20892.
    Webcast Live: https://videocast.nih.gov/summary.asp?live=31473.
    Conference Call Access: Dial: 800-369-3337 Access code: 9975399.
    Cost: The meeting is free and open to the public.
    Registration: A registration web link will be posted on the IACC 
website (www.iacc.hhs.gov) prior to the meeting. Pre-registration is 
recommended to expedite check-in. Seating in the meeting room is 
limited to room capacity and on a first come, first served 
basis.Onsite registration will also be available.
    Deadlines: Notification of intent to present oral comments: 
Thursday, April 4, 2019 by 5:00 p.m. ET. Submission of written/
electronic statement for oral comments: Tuesday, April 9, 2019 by 
5:00 p.m. ET. Submission of written comments: Tuesday, April 9, 2019 
by 5:00 p.m. ET. Webcast Live Feedback Public comments: No 
preregistration required. For instructions, see https://iacc.hhs.gov/meetings/iacc-meetings/live-feedback.shtml. For IACC 
Public Comment guidelines please see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.
    Access: White Flint Metro Station (Red Line).
    Contact Person: Ms. Angelice Mitrakas, Office of Autism Research 
Coordination, National Institute of Mental Health, NIH, 6001 
Executive Boulevard, Room 6182A, Bethesda, MD 20892-9669, Phone: 
301-435-9269, Email: IACCPublicInquiries@mail.nih.gov.

    Public Comments: Any member of the public interested in presenting 
oral comments to the IACC must notify the Contact Person listed on this 
notice by 5:00 p.m. ET on Thursday, April 4, 2019 with their request to 
present oral comments at the meeting, and a written/electronic copy of 
the oral presentation/statement must be submitted by 5:00 p.m. ET on 
Tuesday, April 9, 2019. A limited number of slots for oral comment are 
available, and in order to ensure that as many different individuals 
are able to present throughout the year as possible, any given 
individual only will be permitted to present oral comments once per 
calendar year (2019). Only one representative of an organization will 
be allowed to present oral comments in any given meeting; other 
representatives of the same group may provide written comments. If the 
oral comment session is full, individuals who could not be accommodated 
are welcome to provide written comments instead. Comments to be read or 
presented in the meeting will be assigned a 3-5 minute time slot 
depending on the number of comments, but a longer version may be 
submitted in writing for the record. Commenters going beyond their 
allotted time in the meeting may be asked to conclude immediately in 
order to allow other comments and presentations to proceed on schedule.
    Any interested person may submit written public comments to the 
IACC prior to the meeting by emailing the comments to 
IACCPublicInquiries@mail.nih.gov or by submitting comments at the web 
link: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp by 
5:00 p.m. ET on Tuesday, April 9, 2019. The comments should include the 
name, address, telephone number, and when applicable, the business or 
professional affiliation of the interested person. NIMH anticipates 
written public comments received by 5:00 p.m. ET on Tuesday, April 9, 
2019 will be presented to the Committee prior to the meeting for the 
Committee's consideration. Any written comments received after the 5:00 
p.m. ET, April 9, 2019 deadline through April 16, 2019 will be provided 
to the Committee either before or after the meeting, depending on the 
volume of comments received and the time required to process them in 
accordance with privacy regulations and other applicable Federal 
policies. All written public comments and oral public comment 
statements received by the deadlines for both oral and written public 
comments will be provided to the IACC for their consideration and will 
become part of the public record. Attachments of copyrighted 
publications are not permitted, but web links or citations for any 
copyrighted works cited may be provided.
    Individuals may also submit public comments to the IACC via a Live 
Feedback Form accessible from the webcast page on the day of the 
meeting from 9:00 a.m. ET to 11:00 a.m. ET. No pre-registration 
required. The link will be accessible on the NIH Videocast website at 
https://videocast.nih.gov/summary.asp?live=31473 and instructions are 
available on the IACC website: https://iacc.hhs.gov/meetings/iacc-meetings/live-feedback.shtml. This format is best suited for brief 
questions and comments for the committee. Submissions will be provided 
to the IACC and will become a part of the public record.
    In the 2016-2017 IACC Strategic Plan, the IACC listed the ``Spirit 
of Collaboration'' as one of its core values, stating that, ``We will 
treat others with respect, listen with open minds to the diverse views 
of people on the autism spectrum and their families, thoughtfully 
consider community input, and foster discussions where participants can 
comfortably where participants can comfortably offer opposing 
opinions.'' In keeping with this core value, the IACC and the NIMH 
Office of Autism Research Coordination (OARC) ask that members of the 
public who provide public comments or participate in meetings of the 
IACC also seek to treat others with respect and consideration in their 
communications and actions, even when discussing issues of genuine 
concern or disagreement.
    Remote Access: The meeting will be open to the public through a 
conference call phone number and webcast live on the internet. Members 
of the public who participate using the conference call phone number 
will be able to listen to the meeting but will not be heard. If you 
experience any technical problems with the webcast or conference call, 
please send an email to IACCPublicInquiries@mail.nih.gov or call 240-
668-0302.
    Disability Accommodations: All IACC Full Meetings provide Closed 
Captioning through the NIH videocast website. Remote CART is provided 
through a web application and will be available at all meetings; the 
application can be used on a laptop computer or mobile device. For 
details please inquire with the Contact Person listed on the notice.
    Individuals whose full participation in the meeting will require 
special accommodations (e.g., sign language, or interpreting services, 
etc.) must submit a request to the Contact Person listed on the notice 
at least seven (7) business

[[Page 3800]]

days prior to the meeting. Such requests should include a detailed 
description of the accommodation needed and a way for the IACC to 
contact the requester if more information is needed to fill the 
request. Special requests should be made as early as possible; last 
minute requests may be made but may not be possible to accommodate.
    Security: Visitors will be asked to sign in and show one form of 
identification (for example, a government-issued photo ID, driver's 
license, or passport) at the meeting registration desk during the 
check-in process. Pre-registration is recommended. Seating will be 
limited to the room capacity and seats will be on a first come, first 
served basis, with expedited check-in for those who are pre-registered.
    Meeting schedule subject to change.
    Information about the IACC is available on the website: https://www.iacc.hhs.gov.

    Dated: February 7, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-02125 Filed 2-12-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.